kyung-min lee

Has grant

Assistant professor

Hanyang University

South Korea

Research Interests

Explore related searches

Professors in South Korea Professors in Immunology Immunology professors in South Korea

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Kyung-Min Lee is an Assistant Professor at Hanyang University in South Korea. His research focuses on cancer biology, particularly on resistance mechanisms in breast cancer, including targeted therapies and immune evasion. Recent publications include studies on the role of epigenetics and signaling pathways in therapeutic resistance in various breast cancer subtypes.

Recent Grants

Grant: Close

MCL1 and chemotherapy resistance in triple negative breast cancer

Open Date: 2018-01-09

Close Date: 2021-01-08

Articles (8)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (4)

Joonbeom Bae

Korea University

SOUTH KOREA

View details

Ariella Hanker

assistant professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Benjamin Brown

Research Assistant Professor

Vanderbilt University

UNITED STATES

View details

Jonathan Sheehan

Associate Professor

Washington University in Saint Louis School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

kyung-min lee

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (8)

Special Issue: Resistance to Targeted Therapies in Human Cancer

Brain type of creatine kinase induces doxorubicin resistance via TGF-β signaling in MDA-MB-231 breast cancer cells

Epigenetic Repression of STING by MYC Promotes Immune Evasion and Resistance to Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer

Immune Checkpoint Blockades in Triple-Negative Breast Cancer: Current State and Molecular Mechanisms of Resistance

ECM1 is associated with endocrine resistance in ER+ breast cancers

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity.

Nuclear FGFR1 Regulates Gene Transcription and Promotes Antiestrogen Resistance in ER<sup>+</sup> Breast Cancer.

Proline rich 11 (PRR11) overexpression amplifies PI3K signaling and promotes antiestrogen resistance in breast cancer.

Collaborators (4)

Joonbeom Bae

Ariella Hanker

Benjamin Brown

Jonathan Sheehan

Make your next move.